FTB Advisors Inc. maintained its position in Colgate-Palmolive (NYSE:CL) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,248 shares of the company’s stock at the end of the second quarter. FTB Advisors Inc.’s holdings in Colgate-Palmolive were worth $759,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. American Beacon Advisors Inc. purchased a new stake in shares of Colgate-Palmolive in the first quarter worth $102,000. Proficio Capital Partners LLC raised its position in shares of Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after buying an additional 207 shares in the last quarter. OLD Second National Bank of Aurora purchased a new stake in shares of Colgate-Palmolive in the second quarter worth $109,000. Hanson & Doremus Investment Management raised its position in shares of Colgate-Palmolive by 4.5% in the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after buying an additional 70 shares in the last quarter. Finally, Captrust Financial Advisors purchased a new stake in shares of Colgate-Palmolive in the second quarter worth $122,000. 72.96% of the stock is owned by hedge funds and other institutional investors.

In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now owns 60,528 shares in the company, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. Insiders have sold 173,673 shares of company stock worth $12,629,293 in the last 90 days. Company insiders own 1.02% of the company’s stock.

CL has been the topic of a number of recent analyst reports. Jefferies Group reiterated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, August 24th. Macquarie initiated coverage on Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price objective on the stock. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, September 20th. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $75.00 to $84.00 in a research report on Monday, September 25th. Finally, Royal Bank Of Canada reiterated a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $76.04.

Shares of Colgate-Palmolive (NYSE CL) opened at $73.04 on Monday. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The firm has a market capitalization of $64,136.80, a PE ratio of 25.45, a price-to-earnings-growth ratio of 3.34 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter last year, the business posted $0.73 earnings per share. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. equities research analysts forecast that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s payout ratio is 61.78%.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/04/ftb-advisors-inc-has-759000-stake-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.